# FDA Inspection 1267669 - Glaukos Corporation - April 22, 2025

Source: https://www.keypedia.com/records/fda_inspections/glaukos-corporation/1b4713bf-a869-4279-8c47-8e76dc9f26ea
Source feed: FDA_Inspections

> FDA Inspection 1267669 for Glaukos Corporation on April 22, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1267669
- Company Name: Glaukos Corporation
- Inspection Date: 2025-04-22
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: Los Angeles District Office

## Related Documents

- [FDA Inspection 1251714 - 2024-08-15](https://www.keypedia.com/records/fda_inspections/glaukos-corporation/b52e7c7c-618d-4cdf-b0c4-24e750c4da55)
- [FDA Inspection 1068254 - 2018-08-03](https://www.keypedia.com/records/fda_inspections/glaukos-corporation/f50203a2-aa76-4e83-a2a9-cf9662c25875)
- [FDA Inspection 981961 - 2016-06-10](https://www.keypedia.com/records/fda_inspections/glaukos-corporation/ef93c2ae-49ac-4cc7-b9eb-f5638468c92b)
- [FDA Inspection 835427 - 2013-06-11](https://www.keypedia.com/records/fda_inspections/glaukos-corporation/320295f5-d93e-4633-b83a-a6caacf3b5cd)
- [FDA Inspection 835427 - 2013-06-11](https://www.keypedia.com/records/fda_inspections/glaukos-corporation/31bb012e-6841-4b91-b6d3-ee3c6940bd08)

Company: https://www.keypedia.com/companies/glaukos-corporation/9e9a7fd4-2158-4073-b5b9-79ba4fbdde83

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b